Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin. Pemphigus ...

Pemphigus is the term used to describe a group of autoimmune diseases that cause the skin and mucous membranes to become blistered. The conditions may therefore affect areas of the body such as ...

Pemphigus is a group of rare autoimmune disorders that cause blisters and sores on the skin and mucous membranes. Researchers in Israel recently published the results of a study that analyzed the ...

Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?, Archives of Dermatological Research, 299, 5-6, (239 ...

Because the FDA-approved dose for pemphigus vulgaris is the same as the RA dose, some patients have insurance that only covers the RA regimen of the very-expensive medication.

Results of a study showed that antirituximab antibodies are common among patients with pemphigus who have been treated with rituximab, according to data published in JAMA Dermatology.Rituximab is ...

Patients with pemphigus in complete remission had a reduced risk of relapse after receiving an additional rituximab infusion at month 6, according to a study.In the RITUX 3 trial, patients with ...

Rituximab, an anti-CD20 antibody, has a first-line indication for pemphigus in the U.S. and Europe. MMF, an immunosuppressant, is a first-line glucocorticoid-sparing agent.

Le pemphigus est une pathologie bulleuse qui concerne 1 à 2 personnes sur 1 million en France, d'après la Société française de dermatologie.Cette maladie rare d'origine auto-immune apparaît ...

Pemphigus diseases are a rare group of autoimmune conditions characterized by the formation of blisters that affect the skin and / or mucous membranes. Paraneoplastic pemphigus (PNP) is a rare ...